Wilms tumor: Recent advances in clinical care and biology

Seminars in Pediatric Surgery

Volumn 21, Issue 1, 2012, Pages 15-20

  Hamilton, Thomas E ^a   Shamberger, Robert C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Adjuvant therapy; Molecular biology; Wilms tumor

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ANAPLASTIC CARCINOMA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILDHOOD CANCER; CHROMOSOME 16Q; CHROMOSOME 1P; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; DISEASE SEVERITY; DRUG EFFICACY; GENE EXPRESSION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; LONG TERM CARE; LUNG METASTASIS; MOLECULAR BIOLOGY; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; NEPHRECTOMY; NEPHROBLASTOMA; OVERALL SURVIVAL; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION DOSE; RISK FACTOR; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TRANSLATIONAL RESEARCH; TREATMENT DURATION; TREATMENT RESPONSE;

CHILD; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM STAGING; RISK; TRANSLATIONAL MEDICAL RESEARCH; WILMS TUMOR;

EID: 84855908585     PISSN: 10558586     EISSN: 15329453     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2011.10.002     Document Type: Article

References (27)

1. Huff V. Wilms' tumours: About tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer 2011, 11:111-121.
2. D'Angio G.J., Rosenberg H., Sharples K., et al. Position paper: Imaging methods for primary renal tumors of childhood: Costs versus benefits. Med Pediatr Oncol 1993, 21:205-212.
3. Shamberger R.C., Guthrie K.A., Ritchey M.L., et al. Surgery-related factors and local recurrence of Wilms tumor in National Wilms tumor study 4. Ann Surg 1999, 229:292-297.
4. Weirich A., Leuschner I., Harms D., et al. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol 2001, 12:311-319.
5. Godzinski J., van Tinteren H., de Kraker J., et al. Nephroblastoma: Does the decrease in tumor volume under preoperative chemotherapy predict the lymph node status at surgery?. Pediatr Blood Cancer 2011, E-pub ahead of print.
6. de Kraker J., Graf N., van Tinteren H., et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): A randomised controlled trial. Lancet 2004, 364:12293.
7. Grundy P.E., Breslow N.E., Li S., et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol 2005, 23:7312-7321.
8. Green D.M., Breslow N.E., Beckwith J.B., et al. Treatment with nephrectomy only for small stage I/favorale histology Wilms' tumor: A report from National Wilms Tumor Study Group. J Clin Oncol 2001, 19:3719-3724.
9. Shamberger R.C., Anderson J.R., Breslow N.E., et al. Long-term outcomes for infants with key low risk Wilms tumor treated with surgery alone in National Wilms tumor study-5. Ann Surg 2010, 251:555-558.
10. Sredni S.T., Gadd S., Huang C.C., et al. Subsets of very low risk Wilms tumor show distinctive gene expression, histologic, and clinical features. Clin Cancer Res 2009, 15:6800-6809.
11. Perlman E.J., Grundy P.E., Anderson J.R., et al. WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low risk Wilms tumors treated with surgery alone: A children's oncology group study. J Clin Oncol 2011, 29:698-703.
12. Huang C.C., Gadd S., Breslow N., et al. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: A report from the Renal Tumor Committee of the children's Oncology Group. Clin Cancer Res 2009, 15:1770-1778.
13. Dome J.S., Cotton C.A., Perlman E.J., et al. Treatment of anaplastic histology Wilms tumor: Results from the fifth National Wilms' tumor Study. J Clin Oncol 2006, 24:2352-2358.
14. Williams R.D., Al-Saadi R., Natrajan R., et al. Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor. Genes Chromosomes Cancer 2011, 50:982-995.
15. Grundy P., Breslow N., Green D.M., et al. Prognostic factors for children with recurrent Wilms tumor: Results from the Second and Third National Wilms' tumor Study. J Clin Oncol 1989, 7:638-643.
16. Pinkerton C.R., Groot-Loonen J.J., Morris-Jones P.H., et al. Response rate in relapsed Wilms' tumor. A need for effective agents. Cancer 1991, 67:567-571.
17. Green D.M., Cotton C.A., Malogolowkin M., et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2007, 48:493-499.
18. Malogolowkin M., Cotton C.A., Green D.M., et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D and doxorubicin: A report from the National Wilms Tumor Study Group. Pedaitr Blood Cancer 2008, 50:236-241.
19. Warmann S.W., Furtwängler R., Blumenstock G., et al. Tumor biology influences the prognosis of nephroblastoma patients with primary pulmonary metastases: Results from SIOP 93-01/GPOH and SIOP 2001/GPOH. Ann Surg 2011, 254:155-162.
20. Ehrlich P.F., Hamilton T.E., Grundy P., et al. The value of surgery in directing therapy for patients with Wilms tumor with pulmonary disease: A report from the National Wilms Tumor Study Group (national Wilms tumor study 5). J Pediatr Surg 2006, 41:162-167.
21. Szavay P., Luithle T., Graf N., et al. Primary hepatic metastases in nephroblastoma-A report of the SIOP/GPOH study. J Pediatr Surg 2006, 41:168-172.
22. Ehrlich P.F., Ferrer F.A., Ritchey M.L., et al. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: A report from the children's Oncology Group/National Wilms Tumor Study Group. Ann Surg 2009, 250:642-648.
23. Ritchey M., Daley S., Shamberger R.C., et al. Ureteral extension in Wilms' tumor: A report from the National Wilms' tumor Study Group. J Pediatr Surg 2008, 43:1625-1629.
24. Hamilton T.E., Ritchey M.L., Haase G.M., et al. The management of synchronous bilateral Wilms tumor: A report from the National Wilms Tumor Study Group. Ann Surg 2011, 253:1004-1010.
25. Davidoff A.M., Giel D.W., Jones D.P., et al. The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor: The St Jude Children's Research Hospital experience 1999-2006. Cancer 2008, 112:2060-2070.
26. Green D.M., Cotton C.A., Malogolowkin M., et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2007, 48:493-499.
27. Breslow N.E., Collins A.J., Ritchey M.L., et al. End stage renal disease in patients with Wilms tumor: Results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 2005, 174:1972-1975.